Stay updated with breaking news from Simulations Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug discovery services partnership with Sino-American Cancer Foundation focuses on the development of actionable hits against the MTHFD2 target ... | March 28, 2023
Conference call to be on Wednesday, April 5, 2023, at 5 p.m. EDT ... | March 21, 2023
Promising intellectual property resulting from the collaboration with Polish Academy of Sciences will be jointly owned for further development opportunitiesLANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical...
Promising intellectual property resulting from the collaboration with Polish Academy of Sciences will be jointly owned for further development opportunities Simulations Plus, Inc. (Nasdaq: SLP)
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at Oppenheimer’s 33rd Annual Healthcare Conference taking place virtually from March...